QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
AbCellera Biologics
(NASDAQ:ABCL)
7.67
-0.23[-2.91%]
At close: May 23
7.67
00
After Hours: 7:20PM EDT
Day High/Low7.59 - 7.96
52 Week High/Low5.42 - 33.64
Open / Close7.95 / 7.67
Float / Outstanding151.6M / 284.5M
Vol / Avg.865.2K / 1.8M
Mkt Cap2.2B
P/E12.15
50d Avg. Price8.46
Div / Yield-
Payout Ratio-
EPS0.59
Total Float151.6M

AbCellera Biologics (NASDAQ:ABCL), Quotes and News Summary

AbCellera Biologics (NASDAQ: ABCL)

Day High/Low7.59 - 7.96
52 Week High/Low5.42 - 33.64
Open / Close7.95 / 7.67
Float / Outstanding151.6M / 284.5M
Vol / Avg.865.2K / 1.8M
Mkt Cap2.2B
P/E12.15
50d Avg. Price8.46
Div / Yield-
Payout Ratio-
EPS0.59
Total Float151.6M
Benzinga - 6 days ago
Benzinga - May 11, 2022, 7:13AM
Benzinga - May 11, 2022, 5:02AM
Benzinga - May 10, 2022, 4:27PM
Benzinga - May 3, 2022, 9:02AM
Benzinga - Apr 8, 2022, 1:07PM
Benzinga - Feb 25, 2022, 11:20AM
Benzinga - Feb 25, 2022, 6:21AM
Benzinga - Feb 24, 2022, 4:56PM
Benzinga - Feb 14, 2022, 6:31AM
Benzinga - Feb 11, 2022, 3:40PM
Benzinga - Jan 9, 2022, 5:00PM
Benzinga - Dec 21, 2021, 6:15AM
Benzinga - Dec 7, 2021, 3:22PM
Benzinga - Dec 6, 2021, 8:02AM
Benzinga - Dec 3, 2021, 4:05PM
Benzinga - Dec 2, 2021, 9:12AM
Benzinga - Nov 19, 2021, 4:50AM
Benzinga - Nov 15, 2021, 11:55AM
Benzinga - Nov 9, 2021, 5:26PM
load more
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS0.3300.540 0.2100
REV194.670M316.581M121.911M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

AbCellera Biologics Questions & Answers

Q
How do I buy AbCellera Biologics (ABCL) stock?
A

You can purchase shares of AbCellera Biologics (NASDAQ: ABCL) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are AbCellera Biologics's (ABCL) competitors?
A

There are no as such competitors for AbCellera Biologics.

Q
What is the target price for AbCellera Biologics (ABCL) stock?
A

The latest price target for AbCellera Biologics (NASDAQ: ABCL) was reported by Piper Sandler on Wednesday, May 11, 2022. The analyst firm set a price target for 21.00 expecting ABCL to rise to within 12 months (a possible 173.79% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for AbCellera Biologics (ABCL)?
A

The stock price for AbCellera Biologics (NASDAQ: ABCL) is $7.67 last updated May 23, 2022, 8:00 PM UTC.

Q
Does AbCellera Biologics (ABCL) pay a dividend?
A

There are no upcoming dividends for AbCellera Biologics.

Q
When is AbCellera Biologics (NASDAQ:ABCL) reporting earnings?
A

AbCellera Biologics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is AbCellera Biologics (ABCL) going to split?
A

There is no upcoming split for AbCellera Biologics.

Q
What sector and industry does AbCellera Biologics (ABCL) operate in?
A

AbCellera Biologics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.